Withdraw and Retraction:

A withdraw is usually initiated by the authors, who have the right to request a withdraw of manuscript before the article is published, as long as a valid reason is given, but a $200 of APCs need to be paid to cover the peer review and editorial process if it has been accepted. If the editor or staff discovers that the article has been formally published by another journal, this manuscript will be rejected for publication by the journal.


Following COPE's retraction guidelines, post-publication retraction actions are usually initiated by the editorial office, and editors should consider retracting a publication if the following issues are identified:

  • They have clear evidence that the results are unreliable as ethics reasons (fabrication, falsification, plagiarism, redundant publication, etc.) or major error.
  • Data or material without authorization for use.
  • There is evidence that the publication of the article was attributed to a tampered or manipulated peer review process.
  • The author(s) failed to disclose a major competing interest (a.k.a. conflict of interest) that, in the view of the editor, would have unduly affected interpretations of the work or recommendations by editors and peer reviewers.

Once article is retracted, the original link will be retained and clearly identified as a retraction, and a statement will be announced with the initiator and reasons for retraction. All the authors and their institutions will be informed as well.

 Ethical oversight

SyncSci Publishing (The publisher) always follows the Ethical Oversight of COPE, and monitors the entire publication process in accordance with the Principles of Transparency and Best Practice in Scholarly Publishing of COPE, Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals Editors (ICMJE)Directory of Open Access Journals (DOAJ)Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME). Regardless of the possibility of academic fraud, fabricated data, plagiarism, duplicate publications, and other academic unethical behaviors found at any point in the process, it will be stopped immediately and will not move on to the next step, and the article will be rejected.

The Publisher promises that all the information provided by authors will be treated as private and will not be disclosed to third-party organizations, except for the necessary requirements for publication process. The Publisher is fully committed to monitoring that authors, editor, and reviewers must avoid conflicts of interest and ensure the objectivity and fairness of peer review results.

All the editors must take all possible misconducts seriously. All the concerns or complaints on the possible allegations submitted to the journal office will be dealt with appropriately according to the procedure in the COPE flowchart on complaints. A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. AMLER adopts a zero-tolerance policy concerning any ethical violations and academic misconducts in the study and publication process, including but not limited to plagiarism, falsification, fabrication, resubmission. A panel will be formed to investigate the allegation in cases of suspected misconduct or ethical violation. Once the allegations are proven, the manuscript will be rejected for publication. If the article has been officially published, a retraction must be executed. The authors may appeal within 30 days after the decision is made.

For research involving animal and human subjects, the Publisher invites all authors to be deeply concerned about the privacy and welfare of subjects according to Human and Animal Rights. Authors must provide the approval from the institutional ethical regulator or committee and Statement of Informed Consent (verbal or written) from the subjects. In the case of vulnerable populations, informed consent from their families is required. Personally identifiable information (e.g., face, fingerprints, name, etc.) should be concealed as much as possible, and if it is indeed necessary for the content and results of the study, the reasons must be explained, and subjects must be made aware of all the possible implications that may arise from the publication of the study.